pteridines has been researched along with Carcinoma, Small Cell Lung in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prognosis of small cell lung cancer (SCLC) is poor despite its good initial response to chemotherapy." | 1.48 | Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer. ( Lu, G; Wang, Y; Wu, L; Xu, L; Yao, Y; Zhou, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Wu, L | 1 |
| Yao, Y | 1 |
| Lu, G | 1 |
| Xu, L | 1 |
| Zhou, J | 1 |
| Awad, MM | 1 |
| Chu, QS | 1 |
| Gandhi, L | 1 |
| Stephenson, JJ | 1 |
| Govindan, R | 1 |
| Bradford, DS | 1 |
| Bonomi, PD | 1 |
| Ellison, DM | 1 |
| Eaton, KD | 1 |
| Fritsch, H | 1 |
| Munzert, G | 1 |
| Johnson, BE | 1 |
| Socinski, MA | 1 |
1 trial available for pteridines and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).
Topics: Administration, Intravenous; Adult; Aged; Cell Cycle Proteins; Disease-Free Survival; Female; Humans | 2017 |
1 other study available for pteridines and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
Topics: Animals; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; DNA Damage; Female; G | 2018 |